Rivaroxaban (Xarelto®)
NICE TA 287. Guidance in development. Rivaroxaban is green for the initial dose for this indication in line with the primary care DVT pathway.
- Traffic LightAmber (G)
- BNF2.8.2
- Licensed IndicatorsTreatment of PE and preventing DVT and PE in adults.
- ReferenceAPC Aug 12,Nov 12, July 13 and June 14
- Criteria
- ProvisionalNo
Do you want to add this to your CPD record?
Did you find this page helpful?